SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The primate lentivirus auxiliary protein Vpx counteracts an unknown restriction factor that renders human dendritic and myeloid cells largely refractory to HIV-1 infection. Here we identify SAMHD1 as this restriction factor. SAMHD1 is a protein involved in Aicardi-Goutières syndrome, a genetic encephalopathy with symptoms mimicking congenital viral infection, that has been proposed to act as a negative regulator of the interferon response. We show that Vpx induces proteasomal degradation of SAMHD1. Silencing of SAMHD1 in non-permissive cell lines alleviates HIV-1 restriction and is associated with a significant accumulation of viral DNA in infected cells. Concurrently, overexpression of SAMHD1 in sensitive cells inhibits HIV-1 infection. The putative phosphohydrolase activity of SAMHD1 is probably required for HIV-1 restriction. Vpx-mediated relief of restriction is abolished in SAMHD1-negative cells. Finally, silencing of SAMHD1 markedly increases the susceptibility of monocytic-derived dendritic cells to infection. Our results demonstrate that SAMHD1 is an antiretroviral protein expressed in cells of the myeloid lineage that inhibits an early step of the viral life cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, sterile alpha motif and HD domain 1 (SAMHD1) inhibits reverse transcription by depleting the cellular pool of deoxynucleotide triphosphates [63,64]”
From HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This approach was necessary because PU.1 is the master transcriptional regulator necessary for macrophage differentiation and silencing PU.1 prior to infection results in a change in the cellular phenotype that causes resistance to HIV infection72,73.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Rice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., Fuller, J. C., Jackson, R. M., Lamb, T., Briggs, T. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.373 · Cited by 689
A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells
Manel, N., Hogstad, B., Wang, Y., Levy, D. E., Unutmaz, D., & Littman, D. R. (2010) · Nature · doi:10.1038/nature09337 · Cited by 427
Sobhian, B., Laguette, N., Yatim, A., Nakamura, M., Levy, Y., Kiernan, R., & Benkirane, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.04.012 · Cited by 381
Self-citationBlanchet, F. P., Moris, A., Nikolic, D. S., Lehmann, M., Cardinaud, S., Stalder, R., Garcia, E., Dinkins, C., Leuba, F., Wu, L., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.011 · Cited by 295
Self-citationImmunoaffinity Purification of Mammalian Protein Complexes
Nakatani, Y., & Ogryzko, V. (2003) · Methods in Enzymology · doi:10.1016/s0076-6879(03)70037-8 · Cited by 283
DCs and NK cells: critical effectors in the immune response to HIV-1
Altfeld, M., Fadda, L., Frleta, D., & Bhardwaj, N. (2011) · Nature Reviews Immunology · doi:10.1038/nri2935 · Cited by 216
Srivastava, S., Swanson, S. K., Manel, N., Florens, L., Washburn, M. P., & Skowronski, J. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000059 · Cited by 209
Cited by
Items 701–800 of 1,001
Mamede, J. I., Damond, F., de Bernardo, A., Matheron, S., Descamps, D., Battini, J., Sitbon, M., & Courgnaud, V. (2017) · Scientific Reports · doi:10.1038/srep45214 · Cited by 25
Large-Scale Arrayed Analysis of Protein Degradation Reveals Cellular Targets for HIV-1 Vpu
Jain, P., Boso, G., Langer, S., Soonthornvacharin, S., Jesus, P. D. D., Nguyen, Q., Olivieri, K. C., Portillo, A. J., Yoh, S. M., Pache, L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.091 · Cited by 23
“The HIV-2 and simian immunodeficiency virus (SIV)-encoded Vpx protein causes degradation of SAMHD1 to facilitate reverse transcription in myeloid and resting T cells (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundSzaniawski, M. A., Spivak, A. M., Bosque, A., & Planelles, V. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy583 · Cited by 23
Nucleocytoplasmic shuttling of SAMHD1 is important for LINE-1 suppression
Du, J., Peng, Y., Wang, S., Hou, J., Wang, Y., Sun, T., & Zhao, K. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.02.009 · Cited by 23
Bovine Foamy Virus: Shared and Unique Molecular Features In Vitro and In Vivo
Materniak-Kornas, M., Tan, J., Heit-Mondrzyk, A., Hotz‐Wagenblatt, A., & Löchelt, M. (2019) · Viruses · doi:10.3390/v11121084 · Cited by 22
Elimination of rNMPs from mitochondrial DNA has no effect on its stability
Wanrooij, P. H., Tran, P., Thompson, L. J., Carvalho, G., Sharma, S., Kreisel, K., Navarrete, C., Feldberg, A., Watt, D. L., Nilsson, A. K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916851117 · Cited by 24
“By keeping dNTP levels low when they are not required for nDNA replication, SAMHD1 protects cells from viral infections (37, 38).”
BackgroundGhezzi, S., Galli, L., Kajaste‐Rudnitski, A., Turrini, F., Marelli, S., Toniolo, D., Casoli, C., Riva, A., Poli, G., Castagna, A., et al. (2013) · AIDS · doi:10.1097/01.aids.0000432474.76873.5f · Cited by 22
Degradation of SAMHD1 by Vpx Is Independent of Uncoating
Jáuregui, P., Logue, E. C., Schultz, M. L., Fung, S., & Landau, N. R. (2015) · Journal of Virology · doi:10.1128/jvi.03575-14 · Cited by 24
“Knockdown of DCAF1 prior to infection prevented the Vpxinduced degradation of SAMHD1, consistent with previous findings (1, 2, 37, 55), but knockdown of DDB1 had no effect.”
MethodResultLenzi, G. M., Domaoal, R. A., Kim, D., Schinazi, R. F., & Kim, B. (2014) · Retrovirology · doi:10.1186/s12977-014-0111-y · Cited by 22
“Recent studies revealed that Vpx targets SAMHD1 for proteasomal degradation through the E3 ubiquitination pathway [15,16], and the cellular depletion of SAMHD1 leads to elevated dNTP concentrations and accelerated reverse transcription in macrophages, resting CD4 T cells, and DCs [17].”
BackgroundSchaller, T., Goujon, C., & Malim, M. H. (2012) · Science · doi:10.1126/science.1221057 · Cited by 22
Erratum: Efficient delivery of lentiviral vectors into resting human CD4 T cells
Geng, X., Doitsh, G., Yang, Z., Galloway, N. L. K., & Greene, W. C. (2016) · Gene Therapy · doi:10.1038/gt.2015.115 · Cited by 22
Development of Lentiviral Vectors for HIV-1 Gene Therapy with Vif-Resistant APOBEC3G
Delviks-Frankenberry, K. A., Ackerman, D., Timberlake, N. D., Hamscher, M., Nikolaitchik, O. A., Hu, W.-S., Torbett, B. E., & Pathak, V. K. (2019) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2019.10.024 · Cited by 21
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
Hofmann, H., Vanwalscappel, B., Bloch, N., & Landau, N. R. (2016) · Retrovirology · doi:10.1186/s12977-016-0316-3 · Cited by 23
Subversion of Cell Cycle Regulatory Mechanisms by HIV
Rice, A. P., & Kimata, J. T. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.010 · Cited by 21
“Using mass spectrometry technology to identify cellular proteins that co-immunoprecipitated with wild-type but not with a mutant Vpx unable to associate with DCAF1, SAMHD1 was identified as this key restriction factor in non-dividing cells (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundStructure of Escherichia coli dGTP Triphosphohydrolase
Singh, D., Gaweł, D., Itsko, M., Hochkoeppler, A., Krahn, J. M., London, R. E., & Schaaper, R. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.636936 · Cited by 21
“In humans, a dGTPdependent triphosphohydrolase has been identified as SAMHD1, which likewise hydrolyzes dNTPs into the corresponding deoxynucleoside and tripolyphosphate (7, 8).”
BackgroundYang, S., Shan, T., Zhou, Y., Jiang, Y., Tong, W., Liu, F., Wen, F., Zhang, Q., & Tong, G. (2014) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2014.07.024 · Cited by 22
Jin, C., Peng, X., Liu, F., Cheng, L., Xie, T., Lu, X., Wu, H., & Wu, N. (2016) · AIDS · doi:10.1097/qad.0000000000001166 · Cited by 25
“SAMHD1 is a diguanosine triphosphate-dependent phosphatase that mainly hydrolyzes dinucleotide triphosphate (dNTP) into deoxynucleosides and inorganic triphosphoric acid, reducing the nuclear dNTP concentrations required for HIV-1 reverse transcriptase [9,10].”
BackgroundMajerská, J., Feretzaki, M., Glousker, G., & Lingner, J. (2018) · Life Science Alliance · doi:10.26508/lsa.201800121 · Cited by 22
“SAMHD1 is a dNTPase, which restricts HIV-1 replication (Laguette et al, 2011).”
The ability of SAMHD1 to block HIV-1 but not SIV requires expression of MxB
Buffone, C., Kutzner, J., Opp, S., Martínez‐López, A., Selyutina, A., Coggins, S. A., Studdard, L. R., Ding, L., Kim, B., Spearman, P. W., et al. (2019) · Virology · doi:10.1016/j.virol.2019.03.018 · Cited by 22
“An important function of Vpx is its ability to recruit SAMHD1 for proteasomal degradation (Berger et al., 2011; Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundMethodUbiquitination and SUMOylation in HIV Infection: Friends and Foes
Colomer-Lluch, M., Castro‐Gonzalez, S., & Serra-Moreno, R. (2019) · Current Issues in Molecular Biology · doi:10.21775/cimb.035.159 · Cited by 21
“Even though the specific determinants in SAMHD1 necessary for Vpx-mediated degradation are largely unknown, some studies reported that C-terminal sequences on SAMHD1 are recognized by Vpx to load the restriction factor onto the CUL4A-DDB1-DCAF1 E3 ubiquitin ligase complex (Hofmann et al., 2012; Wei et al., 2012).”
BackgroundInfluentialThe missing link: allostery and catalysis in the anti-viral protein SAMHD1
Morris, E. R., & Taylor, I. A. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180348 · Cited by 21
Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy
Castellví, M., Felip, E., Ezeonwumelu, I. J., Badía, R., García-Vidal, E., Pujantell, M., Gutiérrez-Chamorro, L., Teruel, I., Martínez‐Cardús, A., Clotet, B., et al. (2020) · Cancers · doi:10.3390/cancers12030713 · Cited by 25
“Through its dNTPase activity, SAMHD1 maintains the intracellular dNTP pool at levels adequate for DNA replication and repair but below a potentially mutagenic threshold [2].”
BackgroundInfluentialModeling the evolution of SIV sooty mangabey progenitor virus towards HIV-2 using humanized mice
Schmitt, K. P., Kumar, D. M., Curlin, J., Remling‐Mulder, L., Stenglein, M. D., O’Connor, S. L., Marx, P. A., & Akkina, R. (2017) · Virology · doi:10.1016/j.virol.2017.07.005 · Cited by 22
“Env is utilized by HIV-2 in order to overcome the structural differences between simian and human tetherin (Goldstone et al., 2011; Jia et al., 2009; Kwak et al., 2010; Laguette et al., 2011; Le Tortorec and Neil, 2009; Neil et al., 2006, 2008; Usami et al., 2015; Zhang et al., 2009).”
Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives
Thippeshappa, R., Ruan, H., & Kimata, J. T. (2012) · Biology · doi:10.3390/biology1020134 · Cited by 20
“They showed that Vpx interacts with SAMHD1, resulting in its degradation via the proteasome [151,152].”
BackgroundCoon, S., Wang, D., & Wu, L. J. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0039 · Cited by 21
“In contrast, Vpx of less pathogenic HIV type 2 (HIV-2) and certain simian immunodeficiency viruses (such as SIVsm lineage) can induce proteolytic degradation of SAMHD1 and relieve SAMHD1mediated viral restriction in human myeloid cells.(15,16) The lack of Vpx in HIV-1 may benefit HIV-1 as an immune evasion strategy fo…”
HIV-1 Vpr activates host CRL4-DCAF1 E3 ligase to degrade histone deacetylase SIRT7
Zhou, X., Monnie, C. M., DeLucia, M., & Ahn, J. (2021) · Virology Journal · doi:10.1186/s12985-021-01514-2 · Cited by 24
Reassessing neurodegenerative disease: immune protection pathways and antagonistic pleiotropy
Provenzano, F., & Deleidi, M. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.06.006 · Cited by 21
Zaongo, S. D., Ouyang, J., Chen, Y., Jiao, Y., Wu, H., & Chen, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.853346 · Cited by 24
Tada, T., Peng, J.-Y., Dcosta, B. M., & Landau, N. R. (2023) · JCI Insight · doi:10.1172/jci.insight.167306 · Cited by 20
Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies
Tsiverioti, C. A., Gottschlich, A., Trefny, M. P., Theurich, S., Anders, H., Kroiß, M., & Kobold, S. (2024) · Biological Chemistry · doi:10.1515/hsz-2023-0317 · Cited by 23
Immune control of HIV-1 reservoirs
Autran, B., Descours, B., & Bacchus, C. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835fe6d2 · Cited by 20
The role of tripartite motif family members in mediating susceptibility to HIV-1 infection
Rahm, N., & Telenti, A. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835048e1 · Cited by 23
Functional organization of human SAMHD1 and mechanisms of HIV-1 restriction
Ahn, J. (2016) · Biological Chemistry · doi:10.1515/hsz-2015-0260 · Cited by 20
“Using a proteomic approach, Laguette et al., identified that SAMHD1 associates with Vpx, when Vpx is stably expressed in the human monocytic THP-1 cell line (Laguette et al., 2011).”
BackgroundMethodCzubala, M. A., Finsterbusch, K., Ivory, M. O., Mitchell, J. P., Ahmed, Z., Shimauchi, T., Karoo, R. O. S., Coulman, S. A., Gateley, C., Birchall, J. C., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.05.123 · Cited by 23
“M MuLC, autologous MDLC and MDDC express the SAMHD1 protein which is down-regulated by the SIV3 lentivector encoding the Vpx gene (Vpx) in each cell type as previously described (Hrecka et al, 2011, Laguette et al, 2011, Miyagi et al, 2009).”
BackgroundMethodHepatitis B Virus Protein X Induces Degradation of Talin-1
van de Klundert, M. A. A., van den Biggelaar, M., Kootstra, N. A., & Zaaijer, H. L. (2016) · Viruses · doi:10.3390/v8100281 · Cited by 21
“(Vpx) [28], human immunodeficiency virus (HIV) viral protein R (Vpr) [29], and paramyxovirus simian virus 5 V (SV5-V) protein [30], are known to “hijack” this machinery by acting like a DDB1–Cul4A-associated factor (DCAF) in order to specifically degrade a host protein that restricts viral replication, strongly sugges…”
BackgroundLandsberg, C. D., Megger, D. A., Hotter, D., Rückborn, M. U., Eilbrecht, M., Rashidi‐Alavijeh, J., Howe, S., Heinrichs, S., Sauter, D., Sitek, B., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02978 · Cited by 23
The crystal structure of dGTPase reveals the molecular basis of dGTP selectivity
Barnes, C. O., Wu, Y., Song, J., Lin, G., Baxter, E. L., Brewster, A. S., Nagarajan, V., Holmes, A., Soltis, S. M., Sauter, N. K., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814999116 · Cited by 20
“Critical residues involved in dGTP binding, as well as dGTP-1-thiol binding, include (i) π-π stacking interactions between the electron-rich aromatic ring of Phe(391) and the guanosine ring; (ii) hydrogen bonding between Arg(433), Arg(442), Glu(400), and Val(54) and the guanosine ring; (iii) stacking interactions betw…”
BackgroundCurrent advances in HIV vaccine preclinical studies using Macaque models
Liang, B., Li, H., Li, L., Omange, R. W., Hai, Y., & Luo, M. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.094 · Cited by 20
Gene Transduction in Human Monocyte-Derived Dendritic Cells Using Lentiviral Vectors
Satoh, T., & Manel, N. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-218-6_30 · Cited by 20
Immunobiology of Dendritic Cells and the Influence of HIV Infection
Cunningham, A. L., Harman, A. N., Kim, M., Nasr, N., & Lai, J. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4433-6_1 · Cited by 22
HIV-2 Vpx Protein Interacts with Interferon Regulatory Factor 5 (IRF5) and Inhibits Its Function
Cheng, X., & Ratner, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534321 · Cited by 24
“Recently, SAMHD1 was found to be a restriction factor responsible for the inhibition of HIV reverse transcription by depleting cellular dNTP pools (28, 31).”
BackgroundEvidence for Vpr-dependent HIV-1 Replication in Human CD4+CEM.NKR T-Cells
Zhou, T., Dang, Y., Baker, J. J., Zhou, J., & Zheng, Y. (2012) · Retrovirology · doi:10.1186/1742-4690-9-93 · Cited by 20
“limited to the myeloid tissues [32,33], we wondered whether SAMHD1 played a role in these cells.”
Lodge, R., Gilmore, J. C., Barbosa, J. F., Lombard‐Vadnais, F., & Cohen, É. A. (2017) · Viruses · doi:10.3390/v10010013 · Cited by 22
“Similarly, expression of antiviral host factors such as sterile alpha-motif, histidine-aspartic domain-containing protein 1 (SAMHD1) that reduces the pool of cellular deoxyribonucleotides available for reverse transcription influence the levels of productive HIV-1 replication in macrophages [19,20].”
BackgroundForlani, G., Shallak, M., Ramia, E., Tedeschi, A., & Accolla, R. S. (2019) · Retrovirology · doi:10.1186/s12977-019-0498-6 · Cited by 20
A Potent Postentry Restriction to Primate Lentiviruses in a Yinpterochiropteran Bat
Morrison, J. H., Miller, C. M., Bankers, L., Crameri, G. S., Wang, L., & Poeschla, E. M. (2020) · mBio · doi:10.1128/mbio.01854-20 · Cited by 21
“Known early-acting lentivirus-targeted restriction factors include APOBEC3 (A3) family cytidine deaminases (37), TRIM5 (33), TRIMCyp (34), SAMHD1 (38, 39), and MX2 (40–43).”
BackgroundTrinité, B., Chan, C. N., Lee, C. S., & Levy, D. N. (2016) · Journal of Virology · doi:10.1128/jvi.01770-15 · Cited by 19
“It has been recently demonstrated that the cellular protein SAMHD1, which is constitutively expressed in several nondividing cell types such as monocytes/macrophages (47), dendritic cells (48, 49), and resting CD4 T cells (50), functions as a FIG 6 Early HIV-1-induced death of resting peripheral blood T cells results…”
BackgroundNucleotide embargo by SAMHD1: A strategy to block retroviral infection
Pauls, E., Ballana, E., & Esté, J. A. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.12.009 · Cited by 21
Cordes, N., Kolbe, C., Lock, D., Holzer, T., Althoff, D., Schaefer, D., Blaeschke, F., Kotter, B., Karitzky, S., Rössig, C., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.02.013 · Cited by 22
The HUSH epigenetic repressor complex silences PML nuclear body-associated HSV-1 quiescent genomes
Roubille, S., Escure, T., Juillard, F., Corpet, A., Néplaz, R., Binda, O., Seurre, C., Gonin, M., Bloor, S., Cohen, C., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2412258121 · Cited by 22
“However, presently, we cannot dismiss the possibility of additional effects of Vpx on the stability of other cellular targets, such as SAMHD1 (36, 37), or TASOR2 a paralog of TASOR recently described as being part of a HUSH2 complex (38, 39).”
Cellular and Biochemical Mechanisms of the Retroviral Restriction Factor SAMHD1
Wu, L. J. (2013) · ISRN Biochemistry · doi:10.1155/2013/728392 · Cited by 19
“Together, these studies confirmed that Vpx interacts with SAMHD1 and induces proteasomal degradation of SAMHD1 in THP-1 cells or macrophages, which can be restored by treatment with a proteasome inhibitor [21, 22].”
BackgroundInfluentialThe role of HIV-1 Vpr in promoting the infection of nondividing cells and in cell cycle arrest
Sharifi, H. J., Furuya, A. K. M., & de Noronha, C. M. C. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835049e0 · Cited by 21
Wei, W., Guo, H., Gao, Q., Markham, R. B., & Yu, X. (2013) · Journal of Virology · doi:10.1128/jvi.02866-13 · Cited by 20
“Vpx binds DCAF1 by using conserved motifs in helix 1 and helix 3, which in turn recruit other components of the CRL4(DCAF1) E3 ubiquitin ligase (35– 41) to facilitate SAMHD1 ubiquitination and subsequent degradation (18, 20, 22, 35, 36, 38, 39, 41).”
BackgroundKim, J. T., Liu, Y., Kulkarni, R. P., Lee, K. K., Dai, B., Lovely, G. A., Ouyang, Y., Wang, P., Yang, L., & Baltimore, D. (2017) · Science Immunology · doi:10.1126/sciimmunol.aal1329 · Cited by 19
“The first function—LV antigen delivery to DCs—is thought to primarily occur by transduction, which requires overcoming host restriction factors such as SAMHD-1 that block reverse transcription (6).”
BackgroundMereby, S. A., Maehigashi, T., Holler, J. M., Kim, D., Schinazi, R. F., & Kim, B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004567 · Cited by 19
“Vpx induces the proteosomal degradation of SAMHD1 by recruiting the CUL4A/DCAF1 E3 ubiquitin ligase complex (12, 13), which elevates cellular dNTP concentration and, therefore, relieves these primate lentiviruses from suppressed replication kinetics in macrophages (15, 16).”
BackgroundMethodInfluentialXu, X., Li, M., Li, D., Jiang, Z., Liu, C., Shi, X., Wu, C., Chen, X., Lin, G., & Hu, C. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.03.028 · Cited by 19
Host-HIV-1 Interactome: A Quest for Novel Therapeutic Intervention
Shukla, E., & Chauhan, R. (2019) · Cells · doi:10.3390/cells8101155 · Cited by 26
“This could be because the host restriction factor SAMHD1 (SAM domain and HD domain-containing protein 1) regulates the dNTP pool in myeloid cells, thus blocking HIV reverse transcription by controlling the dNTP supply [68].”
BackgroundXu, D., Leister, D., & Kleine, T. (2019) · PLANT PHYSIOLOGY · doi:10.1104/pp.19.01108 · Cited by 19
“SAMHD1 is required to restrict infection by viruses, such as HIV-1, because the dNTPase activity reduces cellular dNTP levels to such low levels that retroviral reverse transcription is limited (Laguette et al., 2011).”
BackgroundAlpha-enolase in viral target cells suppresses the human immunodeficiency virus type 1 integration
Kishimoto, N., Yamamoto, K., Iga, N., Kirihara, C., Abe, T., Takamune, N., & Misumi, S. (2020) · Retrovirology · doi:10.1186/s12977-020-00539-9 · Cited by 20
Meo, S. D., Dell’Oste, V., Molfetta, R., Tassinari, V., Lotti, L. V., Vespa, S., Pignoloni, B., Covino, D. A., Fantuzzi, L., Bona, R., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008855 · Cited by 19
“SAMHD1 activity is best characterized as a host restriction factor for HIV-1 [9–11], while HIV-2 and some related simian viruses (SIVs) encode the antagonist Vpx, an accessory protein targeting SAMHD1 for ubiquitination and proteasomal degradation [9,10,12].”
BackgroundMethodSelf-citationCellular metabolism in the defense against microbes
Pernas, L. F. (2021) · Journal of Cell Science · doi:10.1242/jcs.252023 · Cited by 20
“In turn, SAMHD1-mediated restriction can be counteracted by certain viral proteins that promote the proteasomal degradation of SAMHD1 (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundJu, S. M., Goh, A. R., Kwon, D.-J., Youn, G. S., Kwon, H., Bae, Y. S., Choi, S. Y., & Park, J. (2012) · Molecules and Cells · doi:10.1007/s10059-012-2287-0 · Cited by 19
“(4) Finally, SAMHD1 was recently identified to inhibit HIV-1 infection in human dendritic cells and myeloid cells (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundQin, Y., Li, Y., Liu, W., Tian, R., Guo, Q., Li, S., Li, H., Zhang, D., Zheng, Y., Wu, L. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027609 · Cited by 20
“The antiretroviral protein, namely SAMHD1 (SAM domain HD domain-containing protein 1), has been recently identified to inhibit the early step of HIV-1 replication in dendritic- and myeloid cells [47,48].”
BackgroundSu, B., Lederle, A., Laumond, G., Ducloy, C., Schmidt, S., Decoville, T., & Moog, C. (2014) · Journal of Virology · doi:10.1128/jvi.01748-14 · Cited by 20
“These results suggest that SAMHD1 not only plays a critical role in HIV-1 restriction but may also modulate biological functions occurring during pDC-lymphocyte cross talk, as shown for MoDC (35).”
BackgroundInfluentialInlora, J., Chukkapalli, V., Bedi, S., & Ono, A. (2016) · Journal of Virology · doi:10.1128/jvi.01004-16 · Cited by 21
“Myeloid cells, including macrophages, express high levels of a restriction factor known as SAM domain- and HD domain-containing protein 1 (SAMHD1), which suppresses HIV-1 replication (90, 91).”
BackgroundClinical Interventions in HIV Cure Research
Rasmussen, T. A., & Søgaard, O. S. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0484-2_12 · Cited by 22
Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion
Mohanty, S., & Harhaj, E. W. (2023) · Pathogens · doi:10.3390/pathogens12050735 · Cited by 20
“The cellular SAM domain HD dom in-containing protein 1 (SAMHD1) is highly expressed in myeloid cells and restricts HIV-1 replication through targeting pre-integr tion steps and prevents productive DNA synthesis through depleting the dNTP p ol [78,79].”
Four Decades of HIV: Global Trends, Testing Assays, Treatment, and Challenges
Haris, M., & Abbas, R. (2024) · Zoonoses · doi:10.15212/zoonoses-2023-0039 · Cited by 20
“Deoxynucleoside triphosphate triphosphohydrolase (SAMHD1) is hindered by viral protein x (Vpx) [19].”
BackgroundKitawi, R. C., Ledger, S., Kelleher, A. D., & Ahlenstiel, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052771 · Cited by 24
“The vpx gene, which is encoded by HIV-2, has been found to counter SAMHD1 restriction ability [143].”
BackgroundMouse knockout models for HIV-1 restriction factors
Rehwinkel, J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1646-8 · Cited by 21
“Two proteomic studies identified SAMHD1 as a host protein co-purifying with vpx [67, 68].”
BackgroundResultInfluentialCoevolutionary dynamics between tribe Cercopithecini tetherins and their lentiviruses
Takeuchi, J. S., Ren, F., Yoshikawa, R., Yamada, E., Nakano, Y., Kobayashi, T., Matsuda, K., Izumi, T., Misawa, N., Shintaku, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep16021 · Cited by 18
Long-term HIV-1 infection induces an antiviral state in primary macrophages
Pujantell, M., Badía, R., Ramirez, C., Puig, T., Clotet, B., Ballana, E., Esté, J. A., & Riveira‐Muñoz, E. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.08.004 · Cited by 20
Intertwined: SAMHD1 cellular functions, restriction, and viral evasion strategies
Majer, C., Schüssler, M., & König, R. (2019) · Medical Microbiology and Immunology · doi:10.1007/s00430-019-00593-x · Cited by 21
“In contrast, mutants for key residues of SAMHD1 catalytic site H206 and D207 [2, 21], mutants for residues involved in SAMHD1 allosteric regulation [18, 52] or SAMHD1 deletion mutants that completely or partially lack catalytic HD domain [17, 52], neither restrict HIV-1 replication nor deplete cellular dNTPs, suggesti…”
BackgroundInfluentialDysregulation of the mevalonate pathway during SARS‐CoV‐2 infection: An in silico study
Marti, J. L. G., Wells, A. H., & Brufsky, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26743 · Cited by 21
“SAMHD1 acts as a primary restriction factor for viral replication during HIV infection in mononuclear cells.(28) SAMHD1 expression is upregulated during IFN1‐dependent responses in certain cell types via IRF3.”
BackgroundHIV-1 trans-Infection Mediated by DCs: The Tip of the Iceberg of Cell-to-Cell Viral Transmission
Perez‐Zsolt, D., Regué, D. R., Muñoz‐Basagoiti, J., Aguilar‐Gurrieri, C., Clotet, B., Blanco, J., & Izquierdo‐Useros, N. (2021) · Pathogens · doi:10.3390/pathogens11010039 · Cited by 18
“Noteworthy, DCs are non-permissive to HIV-1 infection, as they express low levels of viral receptor and co-receptors [69], efficiently degrade incoming viruses [70,71] and express several restriction factors such as SAMHD1 that interfere with viral replication [72–77].”
BackgroundGuo, Q., Zhong, Y., Wang, Z., Cao, T., Zhang, M., Zhang, P., Huang, W., Bi, J., Yuan, Y., Ou, M., et al. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100005 · Cited by 19
Dai, L., Lidie, K. B., Chen, Q., Adelsberger, J. W., Zheng, X. M., Huang, D.-W., Yang, J., Lempicki, R. A., Rehman, T. U., Dewar, R. L., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.06.061 · Cited by 18
Thymic HIV-2 Infection Uncovers Posttranscriptional Control of Viral Replication in Human Thymocytes
Nunes‐Cabaço, H., Matoso, P., Foxall, R. B., Rego, R. T., Pires, A. R., Carvalho, T., Pinheiro, A. I., Soares, R. S., & Sousa, A. E. (2014) · Journal of Virology · doi:10.1128/jvi.03047-14 · Cited by 18
“However, in contrast to the HIV-1 genome, the HIV-2 genome encodes the lentiviral accessory protein Vpx, which targets for degradation the restriction factor sterile alpha motif and histidine/aspartic acid domain-containing protein 1 (SAMHD1), a factor that has been shown to limit the productive infection of HIV-1 in…”
BackgroundPoly-proline motif in HIV-2 Vpx is critical for its efficient translation
Miyake, A., Fujita, M., Fujino, H., Koga, R., Kawamura, S., Otsuka, M., Ode, H., Iwatani, Y., Sakai, Y., Doi, N., et al. (2013) · Journal of General Virology · doi:10.1099/vir.0.057364-0 · Cited by 18
“Recently, it has been demonstrated that Vpx induces proteasomal degradation of host factors SAMHD1 (Hrecka et al., 2011; Laguette et al., 2011) and APOBEC3A (Berger et al., 2011), relieving the restriction of virus infection.3These authors contributed equally to this work.”
BackgroundHow SLX4 cuts through the mystery of HIV-1 Vpr-mediated cell cycle arrest
Blondot, M.-L., Dragin, L., Lahouassa, H., & Margottin-Goguet, F. (2014) · Retrovirology · doi:10.1186/preaccept-2057766064124418 · Cited by 19
Latent human cytomegalovirus enhances HIV-1 infection in CD34+ progenitor cells
Cheung, A. K. L., Huang, Y., Kwok, H., Chen, M., & Chen, Z. (2017) · Blood Advances · doi:10.1182/bloodadvances.2016000638 · Cited by 19
Versatility of ARD1/NAA10-mediated protein lysine acetylation
Vo, T. T. L., Jeong, C., Lee, S., Kim, K., Ha, E., & Seo, J. H. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0100-7 · Cited by 22
Higaki, K., Hirao, M., Kawana‐Tachikawa, A., Iriguchi, S., Kumagai, A., Ueda, N., Bo, W., Kamibayashi, S., Watanabe, A., Nakauchi, H., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.07.017 · Cited by 19
“Obtaining high rates of lentiviral transduction in macrophages is difficult because of a range of host restriction factors such as SAMHD1.(44,45)”
BackgroundHuman interleukin-34-derived macrophages have increased resistance to HIV-1 infection
Paquin‐Proulx, D., Greenspun, B. C., Kitchen, S. M., Raposo, R. A. S., Nixon, D. F., & Grayfer, L. (2018) · Cytokine · doi:10.1016/j.cyto.2018.09.006 · Cited by 19
de Sousa-Pereira, P., Abrantes, J., Bauernfried, S., Pierini, V., Esteves, P. J., Keppler, O. T., Pizzato, M., Hornung, V., Fackler, O., & Baldauf, H. (2018) · Journal of General Virology · doi:10.1099/jgv.0.001201 · Cited by 18
HIV-Captured DCs Regulate T Cell Migration and Cell-Cell Contact Dynamics to Enhance Viral Spread
Koh, W. H., Lopez, P., Ajibola, O., Parvarchian, R., Mohammad, U., Hnatiuk, R., Kindrachuk, J., & Murooka, T. T. (2020) · iScience · doi:10.1016/j.isci.2020.101427 · Cited by 17
“Although migratory DCs are less susceptible to productive HIV infection due to high expression of the restriction factor SAMHDI (Laguette et al., 2011), their ability to capture (Bertram et al., 2019) and transmit viral particles to T cells at the site of cell-cell contact, known as trans-infection, has implications o…”
BackgroundManipulation of the nucleotide pool in human, bacterial and plant immunity
Hochhauser, D., & Sorek, R. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01206-w · Cited by 21
A Highly Active Isoform of Lentivirus Restriction Factor SAMHD1 in Mouse
Bloch, N., Gläsker, S., Sitaram, P., Hofmann, H., Shepard, C., Schultz, M. L., Kim, B., & Landau, N. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.743740 · Cited by 17
“The lentiviral restriction factor SAMHD1(2) is a dNTP triphosphohydrolase (1, 2) that inhibits the replication of HIV-1 in myeloid cells (3, 4).”
BackgroundxCT/SLC7A11 antiporter function inhibits HIV-1 infection
Rabinowitz, J., Sharifi, H. J., Martin, H., Marchese, A. M., Robek, M. D., Shi, B., Mongin, A. A., & de Noronha, C. M. C. (2021) · Virology · doi:10.1016/j.virol.2021.01.008 · Cited by 18
SARS‐CoV‐2, HIV, and HPV: Convergent evolution of selective regulation of cGAS–STING signaling
Shen, S., Rui, Y., Wang, Y., Su, J., & Yu, X. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28220 · Cited by 18
Valeri, E., Unali, G., Piras, F., Alezz, M. A., Pais, G., Benedicenti, F., Lidonnici, M. R., Cuccovillo, I., Castiglioni, I., Arévalo, S., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.11.020 · Cited by 17
“10,11 However, counter-acting SAMHD1 through the accessory viral protein Vpx or the addition of exogenous dNs did not signi fi cantly improve transduction of stimulated HSPC. 12 As the antiviral activity of SAMHD1 is limited to non-cycling cells where dNTP availability is already restricted, we…”
Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals
Raposo, R. A. S., Abdel‐Mohsen, M., Holditch, S. J., Kuebler, P., Cheng, R. G., Eriksson, E. M., Liao, W. J., Pillai, S. K., & Nixon, D. F. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0313150 · Cited by 17
“The low susceptibility of myeloid cells to HIV-1 infection has been attributed recently to SAMHD1, which is counteracted by the primate lentivirus auxiliary protein Vpx [20, 21].”
BackgroundThe eukaryotic elongation factor eEF1A1 interacts with SAMHD1
Morrissey, C., Schwefel, D., Ennis-Adeniran, V., Taylor, I. A., Crow, Y. J., & Webb, M. (2014) · Biochemical Journal · doi:10.1042/bj20140203 · Cited by 19
Sang, M., Liu, J.-B., Dai, M., Wu, J., & Ho, W. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.10.008 · Cited by 17
“SAMHD1 has the ability to block the infection of HIV before their reverse transcription in resting CD4+ T cells (Baldauf et al., 2012), dendritic cells and macrophages (Hrecka et al., 2011; Laguette et al., 2011).”
Negative and Positive Selection Pressure During Sexual Transmission of Transmitted Founder HIV-1
Nijmeijer, B. M., & Geijtenbeek, T. B. H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01599 · Cited by 20
“SAMHD1 also targets the early phase of viral infection as it inhibits reverse transcription by depleting the pool of cellular dNTPs (95, 110, 111).”
BackgroundInfluentialMultiomics Investigation Revealing the Characteristics of HIV-1-Infected Cells In Vivo
Aso, H., Nagaoka, S., Kawakami, E., Ito, J., Islam, S., Tan, B. J. Y., Nakaoka, S., Ashizaki, K., Shiroguchi, K., Suzuki, Y., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107887 · Cited by 19
Morris, E. R., Kunzelmann, S., Caswell, S. J., Purkiss, A. G., Kelly, G. P., & Taylor, I. A. (2021) · Biochemistry · doi:10.1021/acs.biochem.0c00944 · Cited by 17
P-Selectin Glycoprotein Ligand 1: A Potential HIV-1 Therapeutic Target
Zaongo, S. D., Liu, Y., Harypursat, V., Song, F., Xia, H., Ma, P., & Chen, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.710121 · Cited by 17
“Tripartite motif-containing protein 5-a (TRIM5-a) (18), APOBEC3 (19), tetherin (20), SAM domain and HD domaincontaining protein 1 (SAMHD1) (21, 22), and serine incorporator 3 (SERINC3)/SERINC5 (23, 24) are examples of a few restriction factors identified thus far.”
BackgroundOo, A., Zandi, K., Shepard, C., Bassit, L., Musall, K., Goh, S. L., Cho, Y., Kim, D., Schinazi, R. F., & Kim, B. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101635 · Cited by 19
“Thus, SAMHD1 protein levels in primary MDMs can be downregulated by the treatment with Vpx-containing viruslike particles (VLPs) (45).”
HIV-1-induced type I IFNs promote viral latency in macrophages
Dickey, L. L., Martins, L. J., Planelles, V., & Hanley, T. M. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ma0422-616r · Cited by 17
Thippeshappa, R., Ruan, H., Wang, W., Zhou, P., & Kimata, J. T. (2013) · Journal of Virology · doi:10.1128/jvi.00338-13 · Cited by 18
Metadata
- Authors
- Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Laguette, Nadine
- Benkirane, Monsef
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7353
- Pages
- 654-657
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3595993
- OpenAlex
- W2069554621
- Cited by
- 1,511
- References
- 27
- Citations by year
- 2026: 45 · 2025: 60 · 2024: 67 · 2023: 67 · 2022: 84 · 2021: 72 · 2020: 82 · 2019: 113 · 2018: 113 · 2017: 109 · 2016: 114 · 2015: 118 · 2014: 134 · 2013: 159 · 2012: 131
- FWCI
- 58.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- SAMHD1, HIV-1 restriction factors, Vpx, dendritic cells, myeloid cells, Aicardi-Goutières syndrome, proteasomal degradation, HIV-1 replication, viral DNA accumulation, phosphohydrolase activity, interferon response, HIV-2, simian immunodeficiency virus
- MeSH terms
- SAM Domain and HD Domain-Containing Protein 1, Cell Line, Dendritic Cells, DNA, Viral, HeLa Cells, Humans, Virus Replication, HIV-1, HIV Infections, U937 Cells, Monomeric GTP-Binding Proteins, Gene Silencing, Myeloid Cells, Proteasome Endopeptidase Complex, Viral Regulatory and Accessory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.